Intelligent Bio Solutions Statistics
Total Valuation
INBS has a market cap or net worth of $5.17 million. The enterprise value is $152,607.
| Market Cap | 5.17M |
| Enterprise Value | 152,607 |
Important Dates
The next estimated earnings date is Friday, August 14, 2026, before market open.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
INBS has 2.39 million shares outstanding. The number of shares has increased by 138.67% in one year.
| Current Share Class | 2.39M |
| Shares Outstanding | 2.39M |
| Shares Change (YoY) | +138.67% |
| Shares Change (QoQ) | +67.70% |
| Owned by Insiders (%) | 3.78% |
| Owned by Institutions (%) | 4.54% |
| Float | 2.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.32 |
| Forward PS | 0.93 |
| PB Ratio | 0.48 |
| P/TBV Ratio | 0.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.11, with a Debt / Equity ratio of 0.21.
| Current Ratio | 2.11 |
| Quick Ratio | 1.80 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -236.73 |
Financial Efficiency
Return on equity (ROE) is -170.19% and return on invested capital (ROIC) is -87.18%.
| Return on Equity (ROE) | -170.19% |
| Return on Assets (ROA) | -57.25% |
| Return on Invested Capital (ROIC) | -87.18% |
| Return on Capital Employed (ROCE) | -109.22% |
| Weighted Average Cost of Capital (WACC) | 20.56% |
| Revenue Per Employee | $71,150 |
| Profits Per Employee | -$211,153 |
| Employee Count | 55 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 3.22 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.13% in the last 52 weeks. The beta is 4.17, so INBS's price volatility has been higher than the market average.
| Beta (5Y) | 4.17 |
| 52-Week Price Change | -88.13% |
| 50-Day Moving Average | 2.55 |
| 200-Day Moving Average | 5.97 |
| Relative Strength Index (RSI) | 39.65 |
| Average Volume (20 Days) | 33,462 |
Short Selling Information
The latest short interest is 106,385, so 4.45% of the outstanding shares have been sold short.
| Short Interest | 106,385 |
| Short Previous Month | 91,169 |
| Short % of Shares Out | 4.45% |
| Short % of Float | 4.90% |
| Short Ratio (days to cover) | 1.13 |
Income Statement
In the last 12 months, INBS had revenue of $3.91 million and -$11.61 million in losses. Loss per share was -$11.36.
| Revenue | 3.91M |
| Gross Profit | 1.85M |
| Operating Income | -11.20M |
| Pretax Income | -11.65M |
| Net Income | -11.61M |
| EBITDA | -10.23M |
| EBIT | -11.20M |
| Loss Per Share | -$11.36 |
Balance Sheet
The company has $6.86 million in cash and $1.85 million in debt, with a net cash position of $5.01 million or $2.10 per share.
| Cash & Cash Equivalents | 6.86M |
| Total Debt | 1.85M |
| Net Cash | 5.01M |
| Net Cash Per Share | $2.10 |
| Equity (Book Value) | 8.75M |
| Book Value Per Share | 4.48 |
| Working Capital | 5.14M |
Cash Flow
In the last 12 months, operating cash flow was -$10.95 million and capital expenditures -$334,248, giving a free cash flow of -$11.29 million.
| Operating Cash Flow | -10.95M |
| Capital Expenditures | -334,248 |
| Depreciation & Amortization | 963,604 |
| Net Borrowing | n/a |
| Free Cash Flow | -11.29M |
| FCF Per Share | -$4.72 |
Margins
Gross margin is 47.25%, with operating and profit margins of -286.13% and -296.77%.
| Gross Margin | 47.25% |
| Operating Margin | -286.13% |
| Pretax Margin | -297.80% |
| Profit Margin | -296.77% |
| EBITDA Margin | -261.51% |
| EBIT Margin | -286.13% |
| FCF Margin | n/a |
Dividends & Yields
INBS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -138.67% |
| Shareholder Yield | -138.67% |
| Earnings Yield | -224.79% |
| FCF Yield | -218.51% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 42.43% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 16, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Dec 16, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
INBS has an Altman Z-Score of -7.53 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.53 |
| Piotroski F-Score | 3 |